Chinese medicine injections have been approved by foreign authoritative journals

Meters within the network coverage (researcher Chun-Chieh Wu Huang Lan) recently held from Beijing Shenfu cardiopulmonary resuscitation research projects open question at news came from members of the Chinese Medical Emergency Branch Director, Beijing Chaoyang Hospital emergency Professor Department Director Li Chunsheng who wrote The article "The Protective Effect of Shenfu Injection on Cardiac Dysfunction after Resuscitation" was published in the high-level official magazine "SHOCK" in the international critical care field.

According to Li Chunsheng, the article published in “SHOCK” is just a beginning. To further verify the effect of Shenfu injection on the survival rate of CPR patients through clinical research, Beijing Chaoyang Hospital will take the lead and unite more than 50 units across the country to develop 1200 clinical cases. Case-based evidence-based medical research to explore the improvement effect of Shenfu injection on survival rate after cardiopulmonary resuscitation and provide evidence for clinical evidence.

It is understood that Shenfu Injection is the first traditional Chinese medicine injection approved and published in SCI authoritative journals. Shenfu injection is a proprietary Chinese medicine made from red ginseng and attached tablets. It is mainly used for sputum abscesses (infectious, hemorrhagic, fluid-free shock, etc.) of yang qi; it can also be used for convulsions, sputum, cough, stomach pain, diarrhea, sputum caused by yang deficiency (qi deficiency). etc., belong to one category of traditional Chinese medicine treatment of cardiovascular disease, cardiovascular disease medicine drug administration, there are a lot of well-known traditional Chinese medicine injection products, such as Ginkgo biloba L., Danhong injection, Shenmai injection. The Shenfu injection was approved by foreign high-level magazines and provided reference for other international injections of cardiovascular diseases.

According rice network - medicine clinical pattern data show that drug competition cardiovascular disease in 2010 10 varieties in market share has seven traditional Chinese medicine injections, account for more than 30% market share of the main varieties and production companies in the following table: